US FDA's Patrick Frey Joins List Of Agency Leadership Departures
Office of New Drug's chief of staff will become Amgen's director of global regulatory policy and R&D.
You may also be interested in...
Dara Corrigan will become Fresenius-Kabi’s VP for global affairs and policy.
Uhl, who shepherded OGD into the user fee era, will retire in February.
US FDA's Woodcock tells the Pink Sheet that goals include eliminating duplication through creation of one safety review process.